Phase 2 Unresectable Locally Recurrent Rectal Cancer Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University31 enrolled1 locationNCT06767007
Recruiting
Phase 2
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University20 enrolled1 locationNCT07297004